Integra Lifesciences Holdings Corp (IART)
22.99
+0.06
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
22.99
0.00 (0.00%)
After-Hours: 16:02
Integra Lifesciences Holdings Market Cap: 1.774B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.769B |
| November 19, 2024 | 1.766B |
| November 18, 2024 | 1.735B |
| November 15, 2024 | 1.766B |
| November 14, 2024 | 1.796B |
| November 13, 2024 | 1.799B |
| November 12, 2024 | 1.914B |
| November 11, 2024 | 1.964B |
| November 08, 2024 | 1.912B |
| November 07, 2024 | 1.968B |
| November 06, 2024 | 2.060B |
| November 05, 2024 | 1.922B |
| November 04, 2024 | 1.861B |
| November 01, 2024 | 1.488B |
| October 31, 2024 | 1.447B |
| October 30, 2024 | 1.503B |
| October 29, 2024 | 1.504B |
| October 28, 2024 | 1.490B |
| October 25, 2024 | 1.462B |
| October 24, 2024 | 1.456B |
| October 23, 2024 | 1.474B |
| October 22, 2024 | 1.480B |
| October 21, 2024 | 1.505B |
| October 18, 2024 | 1.533B |
| October 17, 2024 | 1.524B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.527B |
| October 15, 2024 | 1.505B |
| October 14, 2024 | 1.483B |
| October 11, 2024 | 1.483B |
| October 10, 2024 | 1.486B |
| October 09, 2024 | 1.396B |
| October 08, 2024 | 1.349B |
| October 07, 2024 | 1.344B |
| October 04, 2024 | 1.311B |
| October 03, 2024 | 1.307B |
| October 02, 2024 | 1.336B |
| October 01, 2024 | 1.350B |
| September 30, 2024 | 1.402B |
| September 27, 2024 | 1.386B |
| September 26, 2024 | 1.355B |
| September 25, 2024 | 1.330B |
| September 24, 2024 | 1.387B |
| September 23, 2024 | 1.361B |
| September 20, 2024 | 1.350B |
| September 19, 2024 | 1.355B |
| September 18, 2024 | 1.360B |
| September 17, 2024 | 1.331B |
| September 16, 2024 | 1.344B |
| September 13, 2024 | 1.355B |
| September 12, 2024 | 1.369B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.307B
Minimum
Oct 03 2024
6.479B
Maximum
Apr 27 2021
4.251B
Average
4.416B
Median
Mar 14 2023
Market Cap Benchmarks
| Boston Scientific Corp | 134.86B |
| Haemonetics Corp | 4.292B |
| ResMed Inc | 35.76B |
| Globus Medical Inc | 11.56B |
| Perspective Therapeutics Inc | 202.09M |
Market Cap Related Metrics
| PS Ratio | 1.137 |
| Price to Book Value | 1.166 |
| Price to Free Cash Flow | 46.78 |
| Price | 22.99 |
| Earnings Yield | -0.39% |
| Operating PE Ratio | 61.72 |